Australian Pharma Stock News

Earlier in February 2026, Santana Minerals Limited announced firm commitments for an A$130,000,000 follow-on equity offering at A$0.90 per share, issuing more than 144 million new ordinary shares at a small discount to fund its Bendigo Ophir Gold Project and broader exploration work. A key backdrop to this capital raise is the company’s recently declared extensional Exploration Target at the Rise & Shine deposit, which outlines additional potential mineralisation supported by step-out...

As the Australian market navigates a busy reporting day with major companies revealing their financial results, there's an optimistic outlook buoyed by positive movements in global markets. The term 'penny stocks' might seem outdated, but these smaller or newer companies still offer intriguing opportunities for investors seeking value and growth potential. By focusing on those with solid financials and clear growth trajectories, penny stocks can present hidden opportunities worth exploring.

We feel now is a pretty good time to analyse Fluence Corporation Limited's ( ASX:FLC ) business as it appears the...

Some Bravura Solutions Limited ( ASX:BVS ) shareholders may be a little concerned to see that the Non-Executive...

Toubani Resources Limited ( ASX:TRE ) is possibly approaching a major achievement in its business, so we would like to...

DEXUS (ASX:DXS) has released its H1 2026 scorecard with Funds From Operations of A$339.4 million, total revenue of A$724.5 million and net income of A$125.8 million, translating into basic EPS of A$0.12. The group has seen total revenue move from A$100.8 million in H2 2024 to A$560.2 million in H1 2025 and A$724.5 million most recently. Over the same period, basic EPS has shifted from a loss of A$0.92 to A$0.01 and then A$0.12, highlighting a sharp reset in margins that puts the focus on how...

Financial results snapshot and how they fit the Suncorp story Suncorp Group (ASX:SUN) has kicked off H1 2026 with a trailing twelve month revenue base of about A$15.1 billion and basic EPS of A$0.91. This sets the context for its latest reported half year, where H2 2025 revenue was A$7.6 billion and EPS came in at A$0.67. Over the last few reported halves, revenue has moved from A$6.6 billion in H2 2024 to A$7.4 billion in H1 2025 and then A$7.6 billion in H2 2025. Over the same periods,...

Australian Finance Group H1 2026 Earnings Snapshot Australian Finance Group (ASX:AFG) has put fresh numbers on the table for H1 2026, with trailing 12 month revenue of A$1.3b and basic EPS of A$0.16 framing the latest result. The company has seen revenue move from A$513.6 million in H2 2024 to A$623.4 million in H1 2025 and A$607.5 million in H2 2025, while basic EPS tracked from A$0.054 in H2 2024 to A$0.056 in H1 2025 and A$0.073 in H2 2025. These figures set up this period’s read through...

Some Evolution Mining Limited ( ASX:EVN ) shareholders may be a little concerned to see that the Non-Executive...

Netwealth Group (ASX:NWL) has just reported its H1 2026 results, with H2 2025 revenue at A$169.0 million and basic EPS of A$0.24, alongside trailing 12 month revenue of A$362.8 million and EPS of A$0.23. The company has seen revenue move from A$131.9 million and EPS of A$0.18 in H2 2024 to A$155.4 million and EPS of A$0.24 in H1 2025, then to A$169.0 million and EPS of A$0.24 in H2 2025. These developments set the stage for investors to weigh the latest numbers against a backdrop of softer...

Servcorp (ASX:SRV) has reported its H1 2026 results with total revenue of A$182.1 million and basic EPS of A$0.19, setting the tone for how the rest of the year might shape up for shareholders focused on the income line. The company has seen revenue move from A$158.7 million in H2 2024 to A$167.7 million in H1 2025 and then to A$182.1 million in H2 2025, while basic EPS over those same halves came in at A$0.20, A$0.35 and A$0.19 respectively. This gives investors a clear view of how the top...

As the Australian stock market experiences a positive trend, buoyed by a robust February reporting season and modest gains on Wall Street, investors are keenly observing potential opportunities among undervalued stocks. In this environment, identifying stocks trading below their estimated intrinsic value can be particularly appealing for those looking to capitalize on favorable market conditions.

Over the last 7 days, the Australian market has remained flat, but over the past year, it has risen by 4.4%, with earnings forecasted to grow by 12% annually. Penny stocks may be a throwback term, but they continue to represent intriguing opportunities for growth at lower price points. By focusing on smaller or newer companies with strong balance sheets and solid fundamentals, investors can uncover hidden gems that offer potential upside without many of the typical risks associated with this...

Mirvac Group (ASX:MGR) has put fresh numbers on the table for H1 2026, with revenue of A$1.5b and basic EPS of A$0.017, setting the tone for how its earnings profile is evolving at a A$2.04 share price. The group has seen revenue move from A$1.8b in H2 2024 to A$1.2b in H1 2025 and then to A$1.5b in H2 2025, while basic EPS shifted from a loss of A$0.153 in H2 2024 to A$0.0003 in H1 2025 and A$0.017 in H2 2025. This progression gives investors a clearer read on how margins are tracking across...

Lottery (ASX:TLC) has laid out its H1 2026 scorecard, reporting revenue of A$1.97b and basic EPS of A$0.085. The company has seen revenue move from A$2.11b in H2 2024 to A$1.78b in H1 2025 and A$1.97b in H2 2025, while basic EPS has tracked from A$0.088 to A$0.079 and then A$0.085 over the same periods. This gives investors a clearer view of how the top and bottom line are pairing up. With net income at A$189.8m this half and net profit margins holding steady year over year, the latest...

Healius (ASX:HLS) has reported its H1 2026 numbers with revenue of A$688.1 million and a basic EPS loss of A$0.04 per share, keeping the focus firmly on how quickly its earnings profile can stabilise from here. The company has seen first half revenue move from A$620.8 million in H1 2024 to A$688.1 million in H1 2025, while basic EPS has shifted from a loss of A$1.08 per share to a smaller loss of A$0.04 per share. The current release therefore lands against a backdrop of heavy but narrowing...

Vicinity Centres H1 2026 earnings snapshot Vicinity Centres (ASX:VCX) has put fresh numbers on the table for H1 2026, with H2 2025 revenue at A$677.2 million and basic EPS of A$0.112, backed by funds from operations of A$329.7 million. The group has seen recent revenue move from A$669.8 million in H2 2024 to A$702.3 million in H1 2025 and then A$677.2 million in H2 2025, while basic EPS shifted from A$0.071 in H2 2024 to A$0.108 in H1 2025 and A$0.112 in H2 2025. For investors, the mix of...

Australian Clinical Labs (ASX:ACL) is in focus after reporting half year 2025 results that show lower net income while sales remained close to prior levels, and the company also declared a fully franked interim dividend. See our latest analysis for Australian Clinical Labs. The latest half year result and interim dividend have arrived against a weaker backdrop for shareholders, with the share price at A$2.15 after a 30 day share price return decline of 15.35% and a 1 year total shareholder...

SEEK H1 2026 Earnings: Headline Results SEEK (ASX:SEK) has posted its H1 2026 numbers, with investors looking back to the recent H2 2025 performance, where revenue was A$560.8 million and basic EPS came in at A$0.28, alongside net income from ongoing operations of A$98.5 million. The company reported revenue of A$526.1 million in H2 2024 and A$560.8 million in H2 2025, while EPS shifted from a loss of A$0.25 to a profit of A$0.28 over the same halves. This sets the scene for a results season...

Judo Capital Holdings (ASX:JDO) has put up a solid H1 2026 scorecard, with revenue of A$205.6 million and net income of A$59.9 million, translating to basic EPS of A$0.053504 and setting the tone for how the rest of the year might look. The bank has seen revenue move from A$172.1 million in H1 2025 to A$175.3 million in H2 2025 and then to A$205.6 million in H1 2026, while basic EPS has stepped from A$0.036738 to A$0.040714 to A$0.053504 over the same periods, giving investors a clear view of...

Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure. See our latest analysis for Botanix Pharmaceuticals. That equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...

Australian shares are on the rise, bolstered by a strong February reporting season and modest gains on Wall Street, contributing to an optimistic outlook for investors. For those willing to explore beyond the well-known blue-chip stocks, penny stocks—often representing smaller or newer companies—offer intriguing possibilities. While the term may seem outdated, these stocks continue to present opportunities for growth at lower price points when supported by solid financials and fundamentals.

Zip Co (ASX:ZIP) has launched a new brand platform called "In You We Trust". The company has rolled out a national "You Trust Me?" campaign to support the new positioning. Alongside the branding shift, Zip Co is introducing product updates and new app features focused on trust and flexibility. Zip Co operates in digital financial services, where competition from both traditional banks and newer fintechs has been intense. By centering its new platform on trust and customer control, ASX:ZIP...

We'd be surprised if QEM Limited ( ASX:QEM ) shareholders haven't noticed that an insider, Gavin Loyden, recently sold...